Longeveron LLC
LGVN
$1.50-13.29%
End of day · as of Oct 16, 2026, 1:30 AM ET
Mkt cap
$26.54M
EV/Sales
18.2
P/E ratio
N/A
FY2025 Revenue
$1.20M
EPS (FY2025)
$-0.00
Gross Margin (FY2025)
66.97%
Profit Margin (FY2025)
-1893.58%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Longeveron LLC (LGVN) is a biotechnology company listed on NASDAQ.
Latest reported LGVN revenue for 2025-12-31 was $1.2M. Net income was -$22.7M. Revenue was down 49.9% from 2024-12-31 to 2025-12-31. LGVN currently screens at market cap $26.5M.
Use this LGVN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LGVN income, balance, and cash tables.
Longeveron LLC (LGVN) is a biotechnology company in the Healthcare sector.
Latest cached Longeveron LLC (LGVN) revenue for Dec 31, 2025 was $1.2M. Net income was -$22.7M. Statements: https://lician.com/financials/lgvn
Longeveron LLC (LGVN) market capitalization is $26.5M on the latest cached snapshot.
Longeveron LLC (LGVN) cached previous close $1.73; day range $1.38 – $1.71; volume 148,116. Session quote: https://lician.com/quote/lgvn
Longeveron LLC (LGVN) latest cached earnings event is "LGVN earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LGVN filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/lgvn